Better use of existing drugs increases cervical cancer survival and reduces recurrence - report from ESMO2023

Professor Krishnansu Sujata Tewari explains the results from he INTERLACE phase 3 trial, assessed whether a short course of induction chemotherapy prior to chemoradiation could reduce the rate of relapse and death among patients with locally advanced cervical cancer. As part of an analysis of clinical data, the preliminary results will be presented at the European Society for Medical Oncology congress 2023. Video: https://medicaldigest.org/scientific-contents/interview:better-use-existing-drugs-increases-cervical-cancer-survival-and-reduces-recurrence